GEN Exclusives

More »

GEN News Highlights

More »
Jan 30, 2007

Laureate Pharma to Manufacture Trubion’s Cancer Candidate

  • Laureate Pharma will produce Trubion Pharmaceuticals’ non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) drug candidate. TRU-016 targets CD37, an antigen present on B cells.

    The company expects to file an IND for TRU-016 in the second half of 2007 after completing preclinical testing.
    Trubion currently retains all development and commercialization rights for the TRU-016 program.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »